LB Pharmaceuticals Inc’s filing revealed that its 10% Owner Deep Track Biotechnology Maste acquired Company’s shares for reported $30.0 million on Sep 12 ’25. In the deal valued at $15.00 per share,2,000,000 shares were bought. As a result of this transaction, Deep Track Biotechnology Maste now holds 2,686,138 shares worth roughly $53.35 million.
Then, Deep Track Biotechnology Maste bought 666,666 shares, generating $9,999,990 in total proceeds. Upon buying the shares at $15.00, the 10% Owner now owns 666,666 shares.
Before that, Pontifax Management 4 G.P. (20 bought 1,000,000 shares. LB Pharmaceuticals Inc shares valued at $15,000,000 were divested by the 10% Owner at a price of $15.00 per share. As a result of the transaction, Pontifax Management 4 G.P. (20 now holds 1,411,681 shares, worth roughly $28.04 million.
Stifel initiated its LB Pharmaceuticals Inc [LBRX] rating to a Buy in a research note published on October 06, 2025; the price target was $27. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who began to cover the stock in early October with a ‘”an Overweight”‘ rating. Leerink Partners began covering LBRX with “an Outperform” recommendation on October 06, 2025.
Price Performance Review of LBRX
On Monday, LB Pharmaceuticals Inc [NASDAQ:LBRX] saw its stock jump 3.84% to $19.86. Over the last five days, the stock has lost -11.73%. Nevertheless, the stocks have risen 14.80% over the past one year.
Levels Of Support And Resistance For LBRX Stock
The 24-hour chart illustrates a support level at 19.09, which if violated will result in even more drops to 18.31. On the upside, there is a resistance level at 20.68. A further resistance level may holdings at 21.49.
How much short interest is there in LB Pharmaceuticals Inc?
A steep rise in short interest was recorded in LB Pharmaceuticals Inc stocks on 2025-11-28, growing by 19524.0 shares to a total of 0.24 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-31 was 0.22 million shares. There was a rise of 8.05%, which implies that there is a positive sentiment for the stock.
